GIP-GLP-1 dual agonist compounds and methods
US10100097B2 · kind B2 · utility
12Cited by
10References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 3, 2013 |
| Grant date | Oct 16, 2018 |
| Priority date | — |
| Expiry date | May 3, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/605
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to truncated GIP analogs which comprise one or more substitutions as compared to wild-type GIP and which may have the property of an altered, preferably increased GLP-1 activity, e.g. as assessed in in vitro efficacy assays. The invention provides GIP-GLP-1 dual agonist compounds and associated methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.